Antibiotic-resistant infections lead to 700,000 deaths per year worldwide 1 . The roles of phenotypically diverse subpopulations of clonal bacteria in the progression of diseases are unclear. We found that the increasingly pathogenic and antibiotic-resistant pathogen Acinetobacter baumannii harbours a highly virulent subpopulation of cells responsible for disease. This virulent subpopulation possesses a thicker capsule and is resistant to host antimicrobials, which drive its enrichment during infection. Importantly, bacteria harvested from the bloodstream of human patients belong exclusively to this virulent subpopulation. Furthermore, the virulent form exhibits increased resistance to hospital disinfectants and desiccation, indicating a role in environmental persistence and the epidemic spread of disease. We identified a transcriptional 'master regulator' of the switch between avirulent and virulent cells, the overexpression of which abrogates virulence. Furthermore, the overexpression strain is capable of vaccinating mice against lethal challenge. This work highlights a phenotypic subpopulation of bacteria that drastically alters the outcome of infection, and illustrates how knowledge of the regulatory mechanisms controlling such phenotypic switches can be harnessed to attenuate bacteria and develop translational interventions.
that it exhibits phenotypic heterogeneity by rapidly interconverting between cells capable of forming opaque or translucent colonies 23 (Fig. 1a) . A single colony can be sequentially propagated between opaque and translucent states with switching frequencies of ~4-13% in 24 h colonies ( Supplementary Fig. 1 ) and 20-40% in 48 h colonies ( Supplementary Fig. 2 ). We hypothesized that differences in capsule contributed to the opacity differences between virulent opaque (VIR-O) and avirulent translucent (AV-T) cells. Examination of cells by electron microscopy after staining for capsule with ruthenium red revealed that VIR-O cells produce a capsule with a twofold increased thickness compared with AV-T cells (Fig. 1b,c) . In comparison, VIR-O and AV-T cells missing the Wzc tyrosine kinase required for capsule synthesis (Δwzc) failed to produce any capsular material and exhibited a translucent phenotype that was more pronounced than in AV-T cells 24 .
The role of these two phenotypic subpopulations in the progression of disease was unclear. After intranasal inoculation of mice with a 1:1 mixture of the two types of cells, VIR-O cells vastly outcompeted AV-T cells in all organs tested (that is, the lungs, spleen and liver) at 24 h post-infection ( Fig. 1d ). Similar results were obtained in single-infection experiments where mice infected with VIR-O cells harboured over 10,000-fold more bacteria in the lungs than mice infected with AV-T cells (Fig. 1e ). In addition, 1,000-fold more bacteria were recovered in the spleens and livers of the VIR-Oinfected mice than those infected with AV-T cells ( Supplementary  Fig. 3) . Surprisingly, while bacteria recovered from VIR-O-infected mice remained in the VIR-O form (Fig. 1f ), there was a greater than 3,000-fold increase in the frequency of VIR-O cells recovered from the AV-T-infected mice compared with the inoculum (0.01% VIR-O cells in the inoculum of AV-T-infected mice) ( Fig. 1g ). Furthermore, VIR-O cells derived from AV-T colonies regained virulence in mice ( Supplementary Fig. 4 ), confirming that the attenuation of AV-T cells was not due to random mutations within the genome. These results reveal a strong selective pressure for the VIR-O population in vivo. In survival experiments, VIR-O-infected mice rapidly succumbed to disease by day 2, whereas AV-T-infected mice survived (Fig. 1h ). VIR-O and AV-T variants exhibited similar growth rates in both rich and defined media, indicating that intrinsic growth rate differences do not account for the virulence defect of AV-T variants ( Supplementary Fig. 5 ). Taken together, these data Letters NATure MIcrobIology indicate that the VIR-O population is virulent and predominates during in vivo infection, whereas the AV-T population is unable to cause acute disease.
It was unclear which factors were responsible for the enrichment of the VIR-O population following in vivo lung infection (Fig. 1e ). The lung is replete with innate immune antimicrobials including lysozyme, antimicrobial peptides such as cathelicidinrelated antimicrobial peptide (CRAMP), and reactive oxygen species 25, 26 . We hypothesized that VIR-O cells might be more resistant than AV-T cells to such antimicrobials. To test this, we conducted time-kill assays with hydrogen peroxide (which leads to the generation of reactive oxygen species), lysozyme and CRAMP. After 1 h of treatment with each of the three antimicrobials, VIR-O cells vastly outnumbered AV-T cells ( Fig. 2a ). Moreover, VIR-O cells also outnumbered AV-T after treatment with LL-37-the human orthologue of CRAMP ( Supplementary Fig. 6 ). These data highlight that VIR-O cells are more resistant than AV-T cells to diverse innate immune antimicrobials.
To test whether these host defences contributed to the enrichment of the VIR-O subpopulation during in vivo infection, wild-type (WT) mice and triple knockout (TKO) mice lacking a functional reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (cybb -/-; required for the production of reactive oxygen species), CRAMP (cramp -/-) and lysozyme (lysM -/-) were infected with an inoculum of AV-T cells. At 8 h post-infection, lungs from WT mice harboured a higher percentage of VIR-O cells compared with TKO mice (Fig. 2b ). This was despite the overall levels of bacteria being higher in TKO mice than WT mice ( Supplementary  Fig. 7 ). These data indicate that reactive oxygen species, CRAMP and lysozyme specifically contribute to the enrichment of the virulent VIR-O subpopulation during early infection. However, since the VIR-O population was still enriched in TKO mice, this indicates that other host factors are involved as well.
Since the VIR-O subpopulation displayed increased resistance to host-derived antimicrobials, we hypothesized that the cells might also exhibit resistance to hospital disinfectants. The VIR-O and AV-T subpopulations were tested for sensitivity to three of the most commonly used disinfectants-benzethonium chloride (BZT), benzalkonium chloride (BAK) and chlorhexidine gluconate (CHG)and the VIR-O cells displayed increased resistance to all three agents compared with the AV-T cells ( Fig. 2c-e ). In addition to resistance to disinfectants, desiccation resistance is a major contributor to the persistence of A. baumannii in the hospital environment. Following eight days of desiccation, VIR-O cells survived better on dry surfaces compared with AV-T cells (Fig. 2f ). Moreover, while viable bacteria recovered from VIR-O cells remained in the VIR-O form (Fig. 2g ), there was a greater than 5,000-fold increase in the frequency of VIR-O cells recovered from the desiccated AV-T cells 
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NATure MIcrobIology ( Fig. 2h ). Taken together, these data link increased virulence and environmental persistence (resistance to hospital disinfectants and desiccation) to a single phenotypic subpopulation of bacterial cells.
To elucidate factors controlling the VIR-O and AV-T subpopulations, we performed genome-wide transcriptional profiling using RNA sequencing (RNA-Seq). This revealed that a predicted TetR-type transcriptional regulator, ABUW_1645, was among the most differentially expressed regulatory genes between the VIR-O and AV-T subpopulations ( Supplementary Table 1 ). Quantitative real-time polymerase chain reaction (PCR) confirmed that the AV-T population expressed 60-fold higher levels of ABUW_1645 compared with VIR-O cells ( Supplementary Fig.  8 ). Intriguingly, ABUW_1645 expression was reduced significantly as AV-T cells gradually switched to VIR-O ( Supplementary  Fig. 9a ), whereas its expression level in VIR-O cells remained low ( Supplementary Fig. 9b ). An in-frame deletion of ABUW_1645 did not alter the rate of VIR-O to AV-T switching, but the rate of AV-T to VIR-O switching was increased 18-fold relative to WT, indicating a role for ABUW_1645 in maintaining the AV-T state ( Supplementary Fig. 10 ).
Strikingly, overexpression of ABUW_1645 in VIR-O cells (VIR-O/1645) led to a translucent colony morphology and a complete inability to switch back to VIR-O ( Fig. 3a) . AV-T cells overexpressing ABUW_1645 (AV-T/1645) were similarly 'locked' and unable to switch to VIR-O cells (Fig. 3a ). Transcriptional profiling of VIR-O/ vector and VIR-O/1645 cells revealed that ABUW_1645 controlled ~70% of the genes differentially expressed between the VIR-O and AV-T cells ( Supplementary Table 1 ). Taken together, these data identify ABUW_1645 as a key regulator of the VIR-O/AV-T highfrequency phenotypic switch.
Previously identified mutations that either increased (ompR) 27 or decreased (arpB) 28 the rate of VIR-O to AV-T switching did not alter ABUW_1645 expression ( Supplementary Fig. 11a ). Furthermore, the ABUW_1645 deletion did not alter the hyper-switching phenotype of an ompR::Tc mutant ( Supplementary Fig. 11b ). In addition, RNA-Seq data indicated that the expression of ompR or arpB was not altered by ABUW_1645 overexpression ( Supplementary Table 1 ). Therefore, ABUW_1645 regulates phenotypic switching by a pathway separate from that regulated by OmpR or ArpB.
Overexpression of ABUW_1645 in VIR-O cells completely reversed resistance to host antimicrobials ( Fig. 3b ), disinfectants ( Supplementary Fig. 12a ,b) and desiccation ( Supplementary  Fig. 12c,d ). In single-infection experiments, VIR-O cells were recovered from mice infected with either VIR-O/vector or AV-T/vector cells ( Fig. 3c ). In contrast, only AV-T cells were recovered from mice infected with ABUW_1645 overexpression strains ( Fig. 3c ). This was associated with drastic attenuation of both VIR-O/1645 and AV-T/1645 strains, which exhibited a 7-log reduction in bacterial levels in the lungs relative to VIR-O/vector-infected mice (Fig. 3d ). Furthermore, since the ABUW_1645 overexpression strains were even less virulent than AV-T cells, these data indicate that the residual colonization of mice during AV-T infection was in fact due to VIR-O cells, which become enriched during infection. This strongly indicates that AV-T cells do not have the ability to replicate and/or survive during in vivo infection, whereas VIR-O cells are responsible for causing disease. In agreement with these findings, infection of mice with the ABUW_1645 deletion mutant led to the recovery of VIR-O cells. This strain was not attenuated compared with the WT ( Supplementary Fig. 13 ), but the ABUW_1645 overexpression strain was. VIR-O/1645 bacteria were unable to cause a lethal infection, whereas VIR-O/vector cells caused a rapidly lethal infection (Fig. 3e ). These data highlight ABUW_1645 as a critical regulator of virulence, as well as traits associated with persistence in the hospital environment.
Since the VIR-O/1645 strain was completely attenuated in vivo, we tested whether it might protect mice against subsequent lethal challenge with the virulent VIR-O/vector cells. While control mice vaccinated with phosphate buffered saline (PBS) or Escherichia coli K-12 rapidly succumbed to challenge on day 2, mice vaccinated with VIR-O/1645 were completely protected ( Fig. 3f ). These data demonstrate that a strain engineered to be locked to produce only avirulent cells can effectively provide protection against otherwise lethal infection, serving as a live-attenuated vaccine against A. baumannii.
Because VIR-O cells clearly predominate during experimental in vivo murine infection, as well as in conditions that simulate stresses encountered in the hospital environment, we set out to test their abundance in samples from hospitalized human patients. Blood cultures from five patients with systemic A. baumannii infections were directly plated on agar and only VIR-O cells were detected from these clinical isolates (Fig. 3g ). Therefore, similar to experimental infections in mice, VIR-O cells vastly predominate in human 
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infections. In addition, AV-T variants could be selected from the VIR-O cells of each clinical isolate, indicating that this phenotypic switch is present in A. baumannii isolates other than AB5075. Moreover, the expression of ABUW_1645 was significantly higher in the AV-T subpopulation from each isolate, relative to the corresponding VIR-O subpopulation, further supporting the key role of this regulator in the VIR-O to AV-T switch (Fig. 3h ). These results provide clinical evidence from diverse isolates that highlights the critical role of the phenotypic subpopulation of VIR-O cells in human disease. A remaining question is: what advantages does the AV-T subpopulation confer to A. baumannii? A subset of genes upregulated in the AV-T cells are predicted to be involved in the catabolism of aromatic compounds (ABUW_0066, ABUW_0068 and ABUW_0070), generation of free phosphate and sulphur from organic sources (ABUW_0904 and ABUW_2921), iron storage (ABUW_3125) and nutrient transport (ABUW_0143, ABUW_3403 and ABUW_1660). This raises the possibility that the AV-T subpopulation is better suited for natural environments outside the host, where nutrients are limited and bacteria may rely on the uptake and catabolism of atypical compounds for use as nutrients. Indeed, AV-T cells grew to higher yields in a nutrient poor media (Chamberlain's) relative to VIR-O cells (Fig. 4a ). Biofilm formation may facilitate colonization of natural environments, such as in soil and water, and AV-T cells were shown to be more proficient than VIR-O cells at biofilm formation at low temperature (25 °C) ( Fig. 4b) . Furthermore, at low temperature outside the host, ABUW_1645 expression in AV-T cells was increased and was subsequently reduced in cells grown at 37 °C (Fig. 4c) . Correspondingly, when AV-T cells were grown at the host temperature (37 °C), as would occur during infection, their rate of switching to VIR-O cells increased more than 3,400-fold (Fig. 4d ). These data are in agreement with those from mouse infections ( Fig. 1 ) and human samples ( Fig. 3) , in which VIR-O cells vastly outnumber AV-T cells. Taken together, these results suggest that AV-T cells are better suited to survive in certain environmental conditions, and their reduced levels of capsule may even render these cells resistant to bacteriophages 29 . 
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This study reveals a phenotypic switch linking resistance to host antimicrobials, virulence and environmental persistence. The data highlight an unexpected role for specific host innate immune antimicrobials (CRAMP, lysozyme and H 2 O 2 ) in enriching the virulent VIR-O subpopulation during murine infection. Our data clearly demonstrate that VIR-O cells are responsible for causing disease in vivo. In addition to being the predominant cells recovered from infected mice, only VIR-O cells were found in the bloodstream of infected human patients, highlighting their critical role in virulence. It is therefore likely that the bacterial cells shed into the environment by infected patients are in the VIR-O form. Interestingly, VIR-O cells also have an increased ability to resist disinfectants and desiccationtwo stresses encountered in the hospital environment. This suggests that, alarmingly, human infection selects for cells that are best-suited for environmental persistence and that, likewise, the bacterial cells persisting in the environment are those that are most virulent when transmitted to future human hosts. Therefore, the VIR-O subpopulation probably underlies a worrisome cycle present in hospital wards, accounting for the difficulty in eradicating A. baumannii as well as the high virulence of many of these infections.
Phenotypic switches that control virulence have been identified in both bacterial and fungal pathogens and this may also represent a bet-hedging strategy where the avirulent subpopulation has a selective advantage outside the host [30] [31] [32] [33] [34] [35] . Interestingly, a phenotypic switch in Photorhabdus luminescens has similarities to A. baumannii, where a virulent subpopulation is more resistant to host antimicrobials 34 . In addition, in the eukaryote Candida albicans, a phenotypic switch that controls the white-opaque colony transition also has parallels with the A. baumannii system, including subpopulation differences in virulence, cell shape and biofilm formation 35 .
Overexpression of ABUW_1645 completely converted VIR-O cells to AV-T cells, and reversed the virulence and environmental persistence attributes of VIR-O cells (Fig. 3) . Thus, while the VIR-O/AV-T phenotypic switch is critical for facilitating A. baumannii virulence, our data suggest that it could be subverted and turned into an ' Achilles' heel' . Small molecules that drive cells into the AV-T form would render cells avirulent and could represent a potential therapeutic approach for the treatment of infections. Furthermore, we demonstrate that the highly attenuated ABUW_1645 overexpression strain is a promising live-attenuated vaccine candidate against A. baumannii, exerting striking protection against lethal challenge. These findings highlight how knowledge of phenotypic traits endowed by subpopulations of cells can be harnessed to facilitate translational interventions.
Methods
Bacterial strains. A. baumannii strain AB5075 was used in this study. All experiments were performed using the same glycerol stock of VIR-O and AV-T cells that were at least 99.9% pure. For each mouse infection, the bacterial inoculum was checked to verify that each culture maintained the VIR-O or AV-T phenotype. E. coli strain EC100D (Epicentre) was used for all cloning experiments.
Methods to distinguish VIR-O and AV-T variants.
The ability to distinguish between VIR-O and AV-T variants requires the use of a stereo (dissecting) microscope that illuminates the plates from below using a light source with an adjustable angle (oblique lighting). A correct light angle is required to observe the opacity differences and an improper light angle can make opaque colonies look transparent and vice-versa. Each microscope should be standardized with VIR-O and AV-T variants to set the proper angle. VIR-O and AV-T stocks will be made available upon request. Colonies should be grown on agar plates composed of 5 g l -1 tryptone, 2.5 g l -1 yeast extract, 2.5 g l -1 sodium chloride and 8 g l -1 agar (0.5× lysogeny broth (LB)/0.8% agar). The VIR-O and AV-T phenotypes can be observed on regular LB plates, but it is much harder to distinguish the variants. Importantly, the VIR-O and AV-T opacity phenotypes can only be accurately distinguished at high colony density (~100 plate -1 ). At low colony density, both variants look like VIR-O. In addition, VIR-O colonies typically give rise to translucent sectors after 24 h. AV-T colonies rarely sector to VIR-O, yet AV-T colonies can have up to 50% VIR-O cells at 48 h.
Electron microscopy. Colonies of bacteria were collected from culture plates and placed in 0.1 M sodium cacodylate (pH 7.4) buffered fixative that contained 2% paraformaldehyde, 2.5% glutaraldehyde, 0.075 g of ruthenium red and 1.55 g of l-lysine acetate. After 20 min of fixation on ice, samples were centrifuged and washed twice in sodium cacodylate/ruthenium red buffer. Samples were then fixed for a second time for two hours with fixative that did not include the l-lysine acetate. Following two additional sodium cacodylate/ruthenium red buffer washes, samples were placed in 1% osmium tetroxide in sodium cacodylate/ruthenium red buffer for 1 h at room temperature. The fixed bacterial samples were then washed, dehydrated through a graded ethanol series and placed in 100% ethanol. The samples were infiltrated with a mixture of Eponate 12 resin (Ted Pella) and propylene oxide before being placed in pure Eponate 12 resin overnight. All resininfiltrated bacterial samples were polymerized for 48 h in a 60 °C oven. The resinembedded bacterial samples were sectioned to 70-80-nm-thick sections using a Leica UltraCut microtome (Leica Biosystems) and subsequently stained with 5% uranyl acetate and 2% lead citrate. The ultrathin sections were imaged with a JEOL JEM-1400 transmission electron microscope operated at 80 kV and equipped with a Gatan US1000 CCD camera.
Mice. WT C57BL/6 J mice were purchased from The Jackson Laboratory and used at age 8-10 weeks. All experiments used age-and sex-matched mice. TKOs deficient in the gp91 component of the NADPH oxidase, lysozyme and CRAMP were derived by crossing cybb -/-(gp91; The Jackson Laboratory), lysM -/-(lysozyme; generously provided by D. Portnoy at the University of California, Berkeley) and cramp -/-(CRAMP; The Jackson Laboratory) mice. Mice were housed under specific pathogen-free conditions at Yerkes National Primate Center, Emory University. All experimental procedures were approved by the Emory University Institutional Animal Care and Use Committee. Mouse sample sizes were determined based on previous studies that generated highly statistically significant results while also minimizing the number of animals used (five mice per group for the majority of the experiments). Females were used for the majority of the animal experiments. Males were used in some experiments to match available knockout mice. Groups of mice with different genetic backgrounds had to be housed separately, precluding randomization and blinding. Corresponding author(s): Philip Rather, David Weiss
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